EP4069237
TVÍVERKANDI EFNASAMBÖND TIL AÐ BRJÓTA BTK NIÐUR Í GEGNUM UBIQUITÍN PRÓTEASÓMFERLIÐ
:
EP einkaleyfi í gildi á Íslandi:
3.12.2020:
9.4.2025:
20829249.0
:
25.6.2025:
15.7.2025
:
2.12.2040:
2.12.2025
:
BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY
3.12.2020
9.4.2025
25.6.2025
15.7.2025
2.12.2025
:
Nurix Therapeutics, Inc.:
1700 Owens Street Suite 205, San Francisco, CA 94158, US
:
SANDS, Arthur T.:
San Francisco, California 94158, US
:
KELLY, Aileen:
San Francisco, California 94158, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201962943720 P:
4.12.2019:
US
:
202063010524 P:
15.4.2020:
US
:
US2020063176:
3.12.2020
:
A61K 31/497, A61K 31/5377, A61P 35/00, A61P 37/00